Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses.
Respiratory Syncytial virus (RSV) is the leading cause of acute lower respiratory tract viral infection in young children and a major cause of winter hospitalization. Bordetella pertussis is a common cause of bacterial lung disease, affecting a similar age group. Although vaccines are available for...
Main Authors: | Ilaria Schiavoni, Giorgio Fedele, Adriano Quattrini, Manuela Bianco, Corinna Schnoeller, Peter J Openshaw, Camille Locht, Clara M Ausiello |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4072631?pdf=render |
Similar Items
-
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
by: Marcel Thalen, et al.
Published: (2020-09-01) -
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
by: Hana Kammoun, et al.
Published: (2013-01-01) -
A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
by: Rigmor Thorstensson, et al.
Published: (2014-01-01) -
Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways.
by: Giorgio Fedele, et al.
Published: (2010-01-01) -
Protection contre les infections hétérologues par la souche vaccinale atténuée Bordetella pertussis BPZE1
by: Kammoun, Hana
Published: (2012)